StockData
Sangamo Therapeutics, Inc logo

Sangamo Therapeutics, Inc (SGMOQ) stock

SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)

Close on Oct 19, 2026Market cap $39.43MP/E –Yield –

Sangamo Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Sangamo Therapeutics's market cap was $32.62M on Oct 19, 2026, against $135.27M a year earlier. Over the last 5 years it ranged from $17.37M to $1.19B, with a median of $160.76M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$32.62M-68.7%
2025Dec 31, 2025$104.13M-47.4%
2024Dec 31, 2024$197.95M+113.9%
2023Dec 29, 2023$92.54M-80.3%
2022Dec 30, 2022$469.56M-56.4%
2021Dec 31, 2021$1.08B-46.1%
2020Dec 31, 2020$2.00B+119.7%
2019Dec 31, 2019$909.47M-22.2%
2018Dec 31, 2018$1.17B-15.2%
2017Dec 29, 2017$1.38B+540.4%
2016Dec 30, 2016$215.40M-66.3%
2015Dec 31, 2015$639.49M-38.5%
2014Dec 31, 2014$1.04B+21.8%
2013Dec 31, 2013$853.13M+168.5%
2012Dec 31, 2012$317.71M+113.2%
2011Dec 30, 2011$149.02M–

More Sangamo Therapeutics figures

See a number that looks wrong?